Connect Biopharma Holdings LTD (CNTB) — 8-K Filings

8-K Filings (11)

• Connect Biopharma Files 8-K with Exhibits — Apr 23, 2026 Risk: low
  Connect Biopharma Holdings Ltd filed an 8-K on April 23, 2026, primarily for Regulation FD Disclosure, Other Events, and Financial Statements/Exhibits. The fili
• Connect Biopharma Files 8-K on Agreements and Equity Sales — Mar 30, 2026 Risk: medium
  Connect Biopharma Holdings Ltd. filed an 8-K on March 30, 2026, disclosing the entry into a material definitive agreement and unregistered sales of equity secur
• 8-K Filing — Dec 23, 2025
• Connect Biopharma Files 8-K for Regulation FD Disclosure — Sep 16, 2025 Risk: low
  Connect Biopharma Holdings Ltd. filed an 8-K on September 16, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures
• Connect Biopharma Holdings Ltd. Announces Board and Officer Changes — Jul 22, 2025 Risk: medium
  Connect Biopharma Holdings Ltd. announced on July 22, 2025, changes in its board and officer appointments, including the departure of directors and the election
• Connect Biopharma Terminates Material Definitive Agreement — Jul 21, 2025 Risk: medium
  Connect Biopharma Holdings Ltd. announced on July 18, 2025, the termination of a material definitive agreement. The company, incorporated in the Cayman Islands,
• J&J Acquires Connect Biopharma for $1B — Jul 17, 2025 Risk: medium
  Connect Biopharma Holdings Ltd. announced on July 16, 2025, that it has entered into a definitive agreement to be acquired by Johnson & Johnson for approximatel
• Connect Biopharma Files 8-K — Jul 9, 2025 Risk: low
  Connect Biopharma Holdings Ltd. filed an 8-K on July 9, 2025, reporting on various events. The filing indicates the company's principal executive offices are lo
• J&J Acquires Connect Biopharma for $1B — May 14, 2025 Risk: medium
  Connect Biopharma Holdings Ltd. announced on May 14, 2025, that it has entered into a definitive agreement to be acquired by Johnson & Johnson for approximately
• Connect Biopharma Files 8-K — May 13, 2025 Risk: medium
  Connect Biopharma Holdings Ltd. filed an 8-K on May 13, 2025, to report on other events and a Regulation FD disclosure. The filing does not contain specific det
• Connect Biopharma Files 8-K with Regulatory Updates — Apr 1, 2025 Risk: low
  Connect Biopharma Holdings Ltd. filed an 8-K on April 1, 2025, reporting on various events. The filing includes information related to Regulation FD disclosures

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX